U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

Showing 7051 - 7060 of 7086 results

Concept
Status:
Investigational
Source:
INN:NOGAPENDEKIN ALFA [INN]
Source URL:

Class:
CONCEPT

Concept
Status:
Investigational
Source:
INN:RETIFANLIMAB [INN]
Source URL:

Class:
CONCEPT

Concept
Status:
Investigational
Source:
NCT03013491: Phase 1/Phase 2 Solid Tumor
(2017)
Source URL:

Class:
CONCEPT

Concept
Status:
Investigational
Source:
INN:ASTEGOLIMAB [INN]
Source URL:

Class:
CONCEPT

Concept
Status:
Investigational
Source:
INN:SASANLIMAB [INN]
Source URL:

Class:
CONCEPT

Concept
Status:
Investigational
Source:
INN:CINREBAFUSP ALFA [INN]
Source URL:

Class:
CONCEPT

Concept
Status:
Investigational
Source:
INN:AVDORALIMAB [INN]
Source URL:

Class:
CONCEPT

Concept
Status:
Investigational
Source:
INN:ZILTIVEKIMAB [INN]
Source URL:

Class:
CONCEPT

Concept
Status:
Investigational
Source:
INN:PATRITUMAB DERUXTECAN [INN]
Source URL:

Class:
CONCEPT

Concept
Status:
Investigational
Source:
INN:MEZAGITAMAB [INN]
Source URL:

Class:
CONCEPT

Showing 7051 - 7060 of 7086 results